Xeris Biopharma Holdings, Inc.
XERSUnited States
44 filed reports · 365 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
44 reports · Sep 2021 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 52 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 24 | 50 | Sep 2021 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 15 | 3,002 | Sep 2021 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 5 | 2,399 | Dec 2021 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 2 | Open |
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 359 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 7, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 208 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Mar 2, 2026 | 2 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 2, 2026 | 796 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Jan 8, 2026 | 2 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 6, 2025 | 2 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 263 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 170 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 7, 2025 | 2 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 8, 2025 | 2 | Open |
Financial data
365 concepts · 5,451 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial362 concepts · 5,261 facts · Mar 2020 to Jul 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value32 · Mar 2020 to Jun 2026
- Net income loss32 · Mar 2020 to Jun 2026
- Stockholders equity (US GAAP)32 · Mar 2020 to Jun 2026
- Thereafter31 · Mar 2022 to Jun 2026
- Allocated share based compensation expense30 · Sep 2020 to Jun 2026
- Comprehensive income net of tax30 · Sep 2020 to Jun 2026
- Income loss attributable to parent30 · Sep 2020 to Jun 2026
- Income tax expense benefit30 · Sep 2020 to Jun 2026
- Interest income other30 · Sep 2020 to Jun 2026
- Operating income loss30 · Sep 2020 to Jun 2026
- Other nonoperating income expense30 · Sep 2020 to Jun 2026
- Research and development expense30 · Sep 2020 to Jun 2026
- Revenue30 · Sep 2020 to Jun 2026
- Selling general and administrative expense30 · Sep 2020 to Jun 2026
- Accrued returns reserve29 · Dec 2020 to Jun 2026
- Accrued trade discounts and rebates29 · Dec 2020 to Jun 2026
- Amortization of financing costs29 · Dec 2020 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents29 · Dec 2020 to Jun 2026
- Depreciation depletion and amortization29 · Dec 2020 to Jun 2026
- Increase decrease in accounts payable29 · Dec 2020 to Jun 2026
- Increase decrease in accounts receivable29 · Dec 2020 to Jun 2026
- Increase decrease in accrued liabilities29 · Dec 2020 to Jun 2026
- Increase decrease in inventories29 · Dec 2020 to Jun 2026
- Increase decrease in other operating liabilities29 · Dec 2020 to Jun 2026
Product1 concepts · 140 facts · Jun 2021 to Jun 2026
- Revenue140 · Jun 2021 to Jun 2026
Guidance2 concepts · 50 facts · Nov 2021 to Aug 2026
- Revenue Guidance49 · Nov 2021 to Aug 2026
- Revenue Growth Guidance1 · Jul 2024
Segments
140 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service6 members · 140 facts
- Gvoke26 · Jun 2021 to Jun 2026
- Keveyis26 · Jun 2021 to Jun 2026
- Product26 · Jun 2021 to Jun 2026
- Recorlev26 · Jun 2021 to Jun 2026
- Royalty Contract And Other Revenue26 · Jun 2021 to Jun 2026
- Product Other10 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.